Business Description
Shanghai Titan Scientific Co Ltd
ISIN : CNE100005XG3
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 14.37 | |||||
Interest Coverage | 2.94 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.55 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.1 | |||||
3-Year EBITDA Growth Rate | -2.4 | |||||
3-Year EPS without NRI Growth Rate | -13.2 | |||||
3-Year FCF Growth Rate | -22 | |||||
3-Year Book Growth Rate | 20.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.15 | |||||
9-Day RSI | 50.95 | |||||
14-Day RSI | 49.18 | |||||
6-1 Month Momentum % | -46.53 | |||||
12-1 Month Momentum % | -62.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.42 | |||||
Quick Ratio | 1.62 | |||||
Cash Ratio | 0.72 | |||||
Days Inventory | 164.81 | |||||
Days Sales Outstanding | 101.02 | |||||
Days Payable | 28.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.66 | |||||
Dividend Payout Ratio | 0.39 | |||||
Forward Dividend Yield % | 0.66 | |||||
5-Year Yield-on-Cost % | 0.66 | |||||
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -5.95 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 20.73 | |||||
Operating Margin % | 3.3 | |||||
Net Margin % | 1.79 | |||||
FCF Margin % | -23.75 | |||||
ROE % | 1.78 | |||||
ROA % | 1.17 | |||||
ROIC % | 2.61 | |||||
ROC (Joel Greenblatt) % | 4.14 | |||||
ROCE % | 2.84 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 57.03 | |||||
PE Ratio without NRI | 56.26 | |||||
Shiller PE Ratio | 36.5 | |||||
PEG Ratio | 4.98 | |||||
PS Ratio | 1.14 | |||||
PB Ratio | 1.23 | |||||
Price-to-Tangible-Book | 1.38 | |||||
EV-to-EBIT | 43.2 | |||||
EV-to-EBITDA | 43.2 | |||||
EV-to-Revenue | 1.41 | |||||
EV-to-FCF | -5.88 | |||||
Price-to-Graham-Number | 1.86 | |||||
Price-to-Net-Current-Asset-Value | 2.44 | |||||
Earnings Yield (Greenblatt) % | 2.31 | |||||
FCF Yield % | -19.16 |